Sino Biological Introduces ProPure™ Endotoxin-Free Proteins, Setting New Industry Standards
TL;DR
Sino Biological's ProPure™ offers researchers a competitive edge with ultra-pure, endotoxin-free proteins, ensuring superior quality for immunology and vaccine development.
ProPure™ proteins are produced using advanced purification technologies and mammalian expression systems, guaranteeing endotoxin levels below the limit of quantification for sensitive applications.
The launch of ProPure™ supports global health advancements by providing high-purity proteins essential for safe and effective vaccine development and therapeutic protein manufacturing.
Discover how Sino Biological's state-of-the-art C4B facility in Houston is revolutionizing bioprocessing with its new ProPure™ line of endotoxin-free recombinant proteins.
Found this article helpful?
Share it with your network and spread the knowledge!
Sino Biological US, Inc. has announced the launch of ProPure™, a premium line of ultra-pure, endotoxin-free recombinant proteins, manufactured at its Center for Bioprocessing (C4B) facility in Houston, Texas. This innovation represents a significant leap forward in the production of proteins for critical applications in immunology research, vaccine development, and therapeutic protein manufacturing, among others.
The ProPure™ proteins are distinguished by their exceptionally low endotoxin levels, achieved through advanced purification and production technologies. These proteins are produced using mammalian expression systems and proprietary purification protocols, ensuring they meet the highest standards of purity and safety. This is particularly crucial for sensitive applications where even minimal endotoxin contamination could adversely affect research outcomes or patient safety.
Dr. Rob Burgess, Chief Business Officer at Sino Biological US, emphasized the company's dedication to scientific excellence and product safety. The introduction of ProPure™ is a testament to Sino Biological's commitment to supporting the global life sciences community with high-quality, reliable products that facilitate both basic and translational science breakthroughs.
Beyond its standard product offerings, the C4B facility also provides customized protein development services, catering to the unique needs of researchers and biomanufacturers. This flexibility, combined with the launch of ProPure™, underscores Sino Biological's role as a leader in bioprocessing innovation and its ongoing investment in advancing the field of life sciences.
The release of ProPure™ endotoxin-free proteins by Sino Biological is poised to set new industry benchmarks, offering researchers and manufacturers unparalleled quality and consistency in protein products. This development not only enhances the toolkit available for scientific research and therapeutic development but also reinforces the importance of stringent quality standards in the production of biological reagents.
Curated from NewMediaWire
